New Key Statistics Module, Z-Score and F-Score
SHSE:600351 Key Ratios
Market Cap ¥ M | 4,629.53 |
Enterprise Value ¥ M | 4,149.93 |
P/E(ttm) | 21.15 |
PE Ratio without NRI | 21.08 |
Forward PE Ratio | -- |
Price/Book | 1.57 |
Price/Sales | 1.74 |
Price/Free Cash Flow | 9.86 |
Price/Owner Earnings | 33.26 |
Payout Ratio % | 0.49 |
Revenue (TTM) ¥ M | 2,831.00 |
EPS (TTM) ¥ | 0.30 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | 0.10 |
5-y EBITDA Growth Rate % | -3.20 |
y-y EBITDA Growth Rate % | 8.60 |
EV-to-EBIT | 15.70 |
EV-to-EBITDA | 15.70 |
PEG | -- |
Shares Outstanding M | 720.00 |
Net Margin (%) | 7.79 |
Operating Margin % | 13.03 |
Pre-tax Margin (%) | 9.12 |
Quick Ratio | 2.04 |
Current Ratio | 2.60 |
ROA % (ttm) | 5.79 |
ROE % (ttm) | 7.47 |
ROIC % (ttm) | 10.34 |
Dividend Yield % | 2.33 |
Altman Z-Score | 5.57 |
SHSE:600351 Number of Guru Trades
SHSE:600351 Volume of Guru Trades
Gurus Latest Trades with SHSE:600351
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600351 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Yabao Pharmaceutical Group Co Ltd Insider Transactions
No Available Data